Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression profiling of MCF7 cells upon Aminoflavone (AF) or Oncrasin1 (Onc1) treatment

ABSTRACT: Expression profiling of MCF7 cells upon Aminoflavone (AF) or Oncrasin1 (Onc1) treatment

PROVIDER: PRJNA527130 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression profiling of MCF7 cells upon Aminoflavone (AF) or Oncrasin1 (Onc1) treatment

Project description:We used microarrays to detail the global programme of gene expression upon treatment

2019-12-31 | GSE128329 | GEO

Transcriptional changes in MCF7 cells upon ISX treatment

Project description:Transcriptional changes in MCF7 cells upon ISX treatment

| PRJEB43758 | ENA

Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells

Project description:We studied alterations in gene expression profiles of the MCF7 human breast cancer cells caused by bisphenol A, bisphenol AF and glyphosate using Illumina RNA sequencing platform.

2017-07-14 | GSE87701 | GEO

Expression profiling of MCF7 cells upon nutlin3a treatment

Project description: Not available

| S-ECPF-GEOD-30183 | biostudies-other

Expression profile of MCF7 and T47D human breast cancer cell lines upon treatment with the BET bromodomian inhibitor JQ1

Project description:Expression profile of MCF7 and T47D human breast cancer cell lines upon treatment with the BET bromodomian inhibitor JQ1

2017-05-08 | GSE95287 | GEO

Expression profiling of MCF7 cells upon nutlin3a treatment

Project description:The tumor suppressor p53 can induce various biological responses. Yet it is not clear whether it is p53 in vivo promoter selectivity that triggers different transcription programs leading to different outcomes. Our analysis of genome-wide chromatin occupancy by p53 using ChIP-seq (deposited in Sequence Read Archive database as SRP007261) revealed “p53 default program”, i.e. the pattern of major p53-bound sites that is similar upon p53 activation by nutlin3a, RITA or 5-FU in breast cancer cells, despite different biological outcomes triggered by these compounds. Parallel analysis of gene expression allowed identification of 280 previously unknown p53 target genes, including p53-repressed AURKA. The consensus p53 binding motif was present more frequently in p53-induced, than in repressed targets, indicating different mechanisms of gene activation versus repression. We identified several possible cofactors of p53, and found that STAT3 antagonised p53-mediated repression of a subset of genes, including AURKA. Finally, we showed that the expression of the novel p53 targets correlates with p53 status and survival in breast cancer patients. We used microarrays to detail the global programme of gene expression changed upon nutlin3a treatment and knocking-down of STAT3 transcription program MCF7 cell with or without knock-down of STAT3 were treated with nutlin3a and collected for RNA extraction and hybridization on Affymetrix microarrays.

2012-09-07 | E-GEOD-30183 | biostudies-arrayexpress

Expression profiling of MCF7 cells upon nutlin3a treatment

2012-09-07 | GSE30183 | GEO

Gene expression change after Enzalutamide treatment in MCF7 cells

Project description:To explore the mechanism of action of Enzalutamide, we performed RNA-seq to investigate gene expression difference after Enzalutamide treatment in both MCF7 and MCF7 with AR over expression (AROE) cells. RNA-sequencing (RNA-seq) of MCF7 and MCF7 AROE cells with DMSO or Enzalutamide treatment

2022-11-28 | GSE200435 | GEO

Gene expression profiling upon treatment with NTX-301

Project description:Gene expression profiling upon treatment with NTX-301

| PRJNA778722 | ENA

Microarray upon ZMYND8 knockdown in MCF7 cells

Project description:Microarray upon ZMYND8 knockdown in MCF7 cells

| PRJNA417778 | ENA